JNJ vs. PG: Johnson & Johnson vs. Procter & Gamble Stock Comparison

November 11, 2026

How do Johnson & Johnson (JNJ) and Procter & Gamble (PG) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

Johnson & Johnson (JNJ) is classified in the Health Care sector (Pharmaceuticals, Biotechnology & Life Sciences), whereas Procter & Gamble (PG) belongs to Consumer Staples (Household & Personal Products) — their GICS classifications point to very different parts of the market.

Company profile comparison for Johnson & Johnson (JNJ) and Procter & Gamble (PG)
Profile Item	JNJ	PG
Name	Johnson & Johnson	The Procter & Gamble Company
Country/Region	United States	United States
GICS Sector	Health Care	Consumer Staples
GICS Industry Group	Pharmaceuticals, Biotechnology & Life Sciences	Household & Personal Products
GICS Industry	Pharmaceuticals	Household Products
GICS Sub-Industry	Pharmaceuticals	Household Products
Market Capitalization	664.95 billion USD	383.36 billion USD
Currency	USD	USD
Exchange	NYSE	NYSE
Listing Date	January 2, 1962	January 2, 1962
Security Type	Common Stock	Common Stock

Price Performance

Cumulative Growth

JNJ

GSPC

Johnson & Johnson (JNJ) vs. Procter & Gamble (PG), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…

Trailing total returns for Johnson & Johnson (JNJ) and Procter & Gamble (PG). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…

Calendar-year total returns for Johnson & Johnson (JNJ) and Procter & Gamble (PG). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for Johnson & Johnson (JNJ) and Procter & Gamble (PG)
Metric	JNJ	PG
Total Return (1Y)	53.82%	17.45%
Total Return (3Y, Annualized)	27.51%	6.50%
Total Return (5Y, Annualized)	14.71%	5.59%

Risk Profile

Drawdown History

JNJ

GSPC

Johnson & Johnson (JNJ) vs. Procter & Gamble (PG), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…

Distribution of monthly total returns for Johnson & Johnson (JNJ) and Procter & Gamble (PG). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Risk profile metrics for Johnson & Johnson (JNJ) and Procter & Gamble (PG)
Metric	JNJ	PG
Volatility (1Y, Annualized)	21.23%	21.15%
Beta (5Y)	0.21	0.35
Max Drawdown (5Y)	-18.41%	-23.77%
Avg. Volume (3M)	6.93M	9.19M

Risk-Adjusted Performance

Risk-Return Positioning

JNJ and PG are plotted by 1-year volatility (risk) and 1-year return. Each dashed Capital Allocation Line uses that stock's own industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for Johnson & Johnson (JNJ) and Procter & Gamble (PG)
Metric	JNJ	PG
Sharpe Ratio (1Y)	2.33	0.62
Sortino Ratio (1Y)	3.66	0.96

Profitability

ROE (TTM)

Johnson & Johnson (JNJ) at 20.02% sits in the top ROE quartile, while Procter & Gamble (PG) at 29.61% is closer to the peer norm — stronger capital efficiency for JNJ.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

20.02%

Max: 109.18%
JNJ: 20.02%
Q3: 6.23%
Median: -26.66%
Q1: -64.05%
Min: -167.77%

PG

Household & Personal Products industry group

29.61%

Max: 42.18%
Q3: 31.87%
PG: 29.61%
Median: 17.80%
Q1: 9.28%
Min: -14.64%

Johnson & Johnson (JNJ) vs. Procter & Gamble (PG): A comparison of their ROE against their respective Pharmaceuticals, Biotechnology & Life Sciences and Household & Personal Products industry group benchmarks.

Net Margin (TTM)

For every dollar of sales, both Johnson & Johnson (JNJ) at 16.20% and Procter & Gamble (PG) at 18.23% retain more as net profit than most peers, landing in the top net margin quartile of their industries.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

16.20%

Max: 18.05%
JNJ: 16.20%
Q3: 4.78%
Median: 0.00%
Q1: -4.14%
Min: -17.05%

PG

Household & Personal Products industry group

18.23%

Max: 23.47%
PG: 18.23%
Q3: 12.19%
Median: 8.50%
Q1: 3.08%
Min: -9.74%

Johnson & Johnson (JNJ) vs. Procter & Gamble (PG): A comparison of their net margin against their respective Pharmaceuticals, Biotechnology & Life Sciences and Household & Personal Products industry group benchmarks.

Operating Margin (TTM)

Procter & Gamble (PG) at 26.87% shows unusually strong operating efficiency — above its industry’s operating margin range — and Johnson & Johnson (JNJ) at 25.74% also operates in the top quartile.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

25.74%

Max: 83.12%
JNJ: 25.74%
Q3: 14.77%
Median: 0.00%
Q1: -78.82%
Min: -207.40%

PG

Household & Personal Products industry group

26.87%

PG: 26.87%
Max: 23.94%
Q3: 17.03%
Median: 13.15%
Q1: 10.58%
Min: 1.87%

Johnson & Johnson (JNJ) vs. Procter & Gamble (PG): A comparison of their operating margin against their respective Pharmaceuticals, Biotechnology & Life Sciences and Household & Personal Products industry group benchmarks.

Profitability Metrics

Profitability metrics for Johnson & Johnson (JNJ) and Procter & Gamble (PG)
Metric	JNJ	PG
ROE (TTM)	20.02%	29.61%
ROA (TTM)	8.46%	10.49%
Net Margin (TTM)	16.20%	18.23%
Operating Margin (TTM)	25.74%	26.87%
Gross Margin (TTM)	67.78%	50.59%

Growth

Revenue Growth

Procter & Gamble (PG) at 3.26% sits in the top revenue growth quartile, while Johnson & Johnson (JNJ) at 6.05% is closer to the peer norm — faster top-line expansion for PG.

Johnson & Johnson (JNJ) vs. Procter & Gamble (PG): A comparison of their Revenue Growth across different time periods.

EPS Growth

Johnson & Johnson (JNJ) at 90.50% sits in the top EPS growth quartile, while Procter & Gamble (PG) at 1.69% is closer to the peer norm — faster per-share earnings growth for JNJ.

Johnson & Johnson (JNJ) vs. Procter & Gamble (PG): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for Johnson & Johnson (JNJ) and Procter & Gamble (PG)
Metric	JNJ	PG
Revenue Growth (YoY)	6.05%	3.26%
Revenue Growth (3Y CAGR)	5.60%	2.00%
EPS Growth (YoY)	90.50%	1.69%
EPS Growth (3Y CAGR)	17.90%	3.91%

Financial Strength

Current Ratio (MRQ)

Both Johnson & Johnson (JNJ) at 1.02 and Procter & Gamble (PG) at 0.72 run current ratio in the tighter-liquidity quartile of industry peers, leaving thinner cushions against current liabilities than typical competitors.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.02

Max: 25.13
Q3: 12.13
Median: 5.52
Q1: 2.47
JNJ: 1.02
Min: 0.10

PG

Household & Personal Products industry group

0.72

Max: 4.26
Q3: 2.82
Median: 1.84
Q1: 0.92
PG: 0.72
Min: 0.65

Johnson & Johnson (JNJ) vs. Procter & Gamble (PG): A comparison of their current ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Household & Personal Products industry group benchmarks.

Debt / Equity (MRQ)

Both Johnson & Johnson (JNJ) at 0.55 and Procter & Gamble (PG) at 0.70 fund their balance sheets with roughly industry-typical debt-to-equity mixes.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.55

Max: 1.42
Q3: 0.65
JNJ: 0.55
Median: 0.15
Q1: 0.02
Min: 0.00

PG

Household & Personal Products industry group

0.70

Max: 2.30
Q3: 2.12
Median: 0.81
PG: 0.70
Q1: 0.50
Min: 0.01

Johnson & Johnson (JNJ) vs. Procter & Gamble (PG): A comparison of their debt-to-equity ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Household & Personal Products industry group benchmarks.

Financial Strength Metrics

Financial strength metrics for Johnson & Johnson (JNJ) and Procter & Gamble (PG)
Metric	JNJ	PG
Current Ratio (MRQ)	1.02	0.72
Debt / Equity (MRQ)	0.55	0.70
Net Debt / EBITDA	0.79	0.94

Dividends

Dividend Yield (TTM)

Procter & Gamble (PG) at 2.57% earns its spot in the top quartile of its industry’s yields; Johnson & Johnson (JNJ) at 1.94% is past the top of its own peer range — territory where a dividend-safety check matters more than the headline number.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.94%

JNJ: 1.94%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

PG

Household & Personal Products industry group

2.57%

Max: 5.00%
PG: 2.57%
Q3: 2.47%
Median: 1.30%
Q1: 0.00%
Min: 0.00%

Johnson & Johnson (JNJ) vs. Procter & Gamble (PG): A comparison of their dividend yield against their respective Pharmaceuticals, Biotechnology & Life Sciences and Household & Personal Products industry group benchmarks.

Dividend Payout Ratio (TTM)

Procter & Gamble (PG) at 64.62% keeps its payout in the industry’s typical band, while Johnson & Johnson (JNJ) at 80.12% pays out more than any of its peers — the most stretched cover in its group.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

80.12%

JNJ: 80.12%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

PG

Household & Personal Products industry group

64.62%

Max: 140.00%
Q3: 73.75%
PG: 64.62%
Median: 46.43%
Q1: 0.00%
Min: 0.00%

Johnson & Johnson (JNJ) vs. Procter & Gamble (PG): A comparison of their payout ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Household & Personal Products industry group benchmarks.

Dividend Metrics

Dividend metrics for Johnson & Johnson (JNJ) and Procter & Gamble (PG)
Metric	JNJ	PG
Dividend Yield (TTM)	1.94%	2.57%
Dividend Payout Ratio (TTM)	80.12%	64.62%

Valuation

P/E Ratio (TTM)

Both Johnson & Johnson (JNJ) at 41.92 and Procter & Gamble (PG) at 24.91 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

41.92

Max: 85.34
Q3: 43.46
JNJ: 41.92
Median: 26.69
Q1: 13.30
Min: 0.07

PG

Household & Personal Products industry group

24.91

Max: 37.57
Q3: 33.54
PG: 24.91
Median: 20.03
Q1: 15.76
Min: 6.45

Johnson & Johnson (JNJ) vs. Procter & Gamble (PG): A comparison of their P/E ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Household & Personal Products industry group benchmarks.

P/S Ratio (TTM)

Johnson & Johnson (JNJ) at 6.69 is priced about in line with its industry on P/S ratio, while Procter & Gamble (PG) at 4.36 sits in the pricier quartile — PG costs more per dollar of sales.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

6.69

Max: 58.18
Q3: 25.77
Median: 7.30
JNJ: 6.69
Q1: 3.01
Min: 0.01

PG

Household & Personal Products industry group

4.36

PG: 4.36
Max: 4.36
Q3: 3.57
Median: 1.68
Q1: 0.76
Min: 0.30

Johnson & Johnson (JNJ) vs. Procter & Gamble (PG): A comparison of their P/S ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Household & Personal Products industry group benchmarks.

P/B Ratio (MRQ)

Procter & Gamble (PG) at 7.05 is valued about in line with its industry on P/B ratio, while Johnson & Johnson (JNJ) at 8.16 carries an above-peer premium to book — JNJ is pricier on assets.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

8.16

Max: 13.53
JNJ: 8.16
Q3: 6.54
Median: 3.25
Q1: 1.69
Min: -5.59

PG

Household & Personal Products industry group

7.05

Max: 12.30
Q3: 7.43
PG: 7.05
Median: 3.44
Q1: 1.30
Min: -3.91

Johnson & Johnson (JNJ) vs. Procter & Gamble (PG): A comparison of their P/B ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Household & Personal Products industry group benchmarks.

Valuation Metrics

Valuation metrics for Johnson & Johnson (JNJ) and Procter & Gamble (PG)
Metric	JNJ	PG
P/E Ratio (TTM)	41.92	24.91
P/S Ratio (TTM)	6.69	4.36
P/B Ratio (MRQ)	8.16	7.05
Free Cash Flow Yield (TTM)	2.78%	3.30%